Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples